Atrys Health, S.A.

MCE ATRY.MC

Atrys Health, S.A. Shareholders' Equity for the year ending December 31, 2023: USD 319.95 M

Atrys Health, S.A. Shareholders' Equity is USD 319.95 M for the year ending December 31, 2023, a -11.43% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Atrys Health, S.A. Shareholders' Equity for the year ending December 31, 2022 was USD 361.24 M, a 15.80% change year over year.
Atrys Health, S.A. Shareholders' Equity for the year ending December 31, 2021 was USD 311.94 M, a 239.00% change year over year.
Atrys Health, S.A. Shareholders' Equity for the year ending December 31, 2020 was USD 92.02 M, a 105.22% change year over year.
Atrys Health, S.A. Shareholders' Equity for the year ending December 31, 2019 was USD 44.84 M, a 48.16% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

MCE: ATRY.MC

Atrys Health, S.A.

CEO	Ms. Isabel Lozano Fernandez
IPO Date	July 22, 2016
Location	Spain
Headquarters	Calle VelAzquez, 24
Employees	2,084
Sector	Healthcare
Industries Biotechnology Medical Instruments Pharmaceuticals Telehealth

Description

Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. The company offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics; and diagnostic second opinion, test directory, and clinical trials and R&D services. It uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology. The company also provides radiotherapy; and develops therapeutic modalities and diagnostic tools. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.

Key trends

Past 5 years